JANUARY 2022
latest news.
Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo
Transformational Transaction Diversifies Cosette’s Business to Accelerate Future Growth
us.
Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.
leadership.
Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.
products.
While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.
newsroom.
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity
Ganesh Pillarisetti has joined the executive team as Vice President, IT at Cosette Pharmaceuticals.…
Ganesh Pillarisetti has joined Cosette Pharmaceuticals as Vice President, IT
Ganesh Pillarisetti has joined the executive team as Vice President, IT at Cosette Pharmaceuticals.…
Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth
Bridgewater, NJ. July 6, 2022. Cosette Pharmaceuticals, Inc., a New Jersey-based specialty…
